UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 613

Sortiert nach

Chemokine receptor CCR5 antagonist maraviroc: medicinal chemistry and clinical applications

Current topics in medicinal chemistry, 2014-09, Vol.14 (13), p.1504

2014

Link zum Volltext

Verfügbarkeit prüfen

Function-Oriented Development of CXCR4 Antagonists as Selective Human Immunodeficiency Virus (HIV)‑1 Entry Inhibitors

Journal of medicinal chemistry, 2015-02, Vol.58 (3), p.1452-1465

2015

Link zum Volltext

Verfügbarkeit prüfen

Asymmetric Synthesis of (−)-Brevipolide H through Cyclopropanation of the α,β-Unsaturated Ketone

Organic letters, 2014-10, Vol.16 (20), p.5328-5331

2014

Link zum Volltext

Verfügbarkeit prüfen

Design, syntheses, and characterization of piperazine based chemokine receptor CCR5 antagonists as anti prostate cancer agents

Bioorganic & medicinal chemistry letters, 2014-05, Vol.24 (10), p.2319-2323

2014

Link zum Volltext

Verfügbarkeit prüfen

Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis

Journal of acquired immune deficiency syndromes (1999), 2016-11, Vol.73 (3), p.252

2016

Link zum Volltext

Verfügbarkeit prüfen

Maraviroc reduces neuropathic pain through polarization of microglia and astroglia – Evidence from in vivo and in vitro studies

Neuropharmacology, 2016-09, Vol.108, p.207-219

2016

Link zum Volltext

Verfügbarkeit prüfen

The efficacy and safety of maraviroc addition to a stable antiretroviral regimen in subjects with suppressed plasma HIV-RNA is not influenced by age

AIDS research and human retroviruses, 2015-09, Vol.31 (9), p.893

2015

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of Inflammatory and Neuropathic Pain by Targeting a Mu Opioid Receptor/Chemokine Receptor5 Heteromer (MOR-CCR5)

Journal of medicinal chemistry, 2015-11, Vol.58 (21), p.8647-8657

2015

Link zum Volltext

Verfügbarkeit prüfen

Targeting chemokine receptors for HIV: past, present and future

Future medicinal chemistry, 2015-01, Vol.7 (17), p.2311-2315

Fricker, Simon P

2015

Link zum Volltext

Verfügbarkeit prüfen

Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES

Journal of controlled release, 2019-03, Vol.298, p.1-11

2019

Link zum Volltext

Verfügbarkeit prüfen

The applications of PCA in QSAR studies: A case study on CCR5 antagonists

Chemical biology & drug design, 2018-01, Vol.91 (1), p.137-152

2018

Link zum Volltext

Verfügbarkeit prüfen

Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm

Neurochemistry international, 2017-09, Vol.108, p.100-108

2017

Link zum Volltext

Verfügbarkeit prüfen

Design and Elaboration of a Tractable Tricyclic Scaffold To Synthesize Druglike Inhibitors of Dipeptidyl Peptidase‑4 (DPP-4), Antagonists of the C–C Chemokine Receptor Type 5 (CCR5), and Highly Potent and Selective Phosphoinositol‑3 Kinase δ (PI3Kδ) Inhibitors

Journal of medicinal chemistry, 2017-02, Vol.60 (4), p.1534-1554

2017

Link zum Volltext

Verfügbarkeit prüfen

Allosteric mechanism of an oximino‐piperidino‐piperidine antagonist for the CCR5 chemokine receptor

Chemical biology & drug design, 2020-01, Vol.95 (1), p.113-123

2020

Link zum Volltext

Verfügbarkeit prüfen

Exploration on natural product anibamine side chain modification toward development of novel CCR5 antagonists and potential anti-prostate cancer agents

Bioorganic & medicinal chemistry letters, 2015-09, Vol.25 (17), p.3721-3725

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical and immunologic effects of maraviroc in progressive multifocal leukoencephalopathy

Neurology, 2015-07, Vol.85 (1), p.104

2015

Link zum Volltext

Verfügbarkeit prüfen

Medicinal chemistry of small molecule CCR5 antagonists for blocking HIV-1 entry: a review of structural evolution

Current topics in medicinal chemistry, 2014-09, Vol.14 (13), p.1515

2014

Link zum Volltext

Verfügbarkeit prüfen

Molecular Gymnastics: Mechanisms of HIV-1 Resistance to CCR5 Antagonists and Impact on Virus Phenotypes

Current topics in medicinal chemistry, 2016-01, Vol.16 (10), p.1091

2016

Link zum Volltext

Verfügbarkeit prüfen

CCR5 blockade combined with cyclosporine A attenuates liver GVHD by impairing T cells function

Inflammation research, 2016-11, Vol.65 (11), p.917-924

2016

Link zum Volltext

Verfügbarkeit prüfen

CCR5 Blockade Promotes M2 Macrophage Activation and Improves Locomotor Recovery After Spinal Cord Injury in Mice

Inflammation, 2015-02, Vol.38 (1), p.126-133

2015

Link zum Volltext

Verfügbarkeit prüfen

Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model

Inflammation research, 2015-02, Vol.64 (2), p.137-144

2015

Link zum Volltext

Verfügbarkeit prüfen

Screening HIV-1 fusion inhibitors based on capillary electrophoresis head-end microreactor targeting to the core structure of gp41

Journal of pharmaceutical and biomedical analysis, 2016-02, Vol.120, p.153-157

2016

Link zum Volltext

Verfügbarkeit prüfen

Short Communication: Maraviroc Once-Daily: Experience in Routine Clinical Practice

AIDS research and human retroviruses, 2017-01, Vol.33 (1), p.29

2017

Link zum Volltext

Verfügbarkeit prüfen

Design, synthesis, and biological activity of novel 1,4-disubstituted piperidine/piperazine derivatives as CCR5 antagonist-based HIV-1 entry inhibitors

Bioorganic & medicinal chemistry letters, 2012-05, Vol.22 (9), p.3284-3286

2012

Link zum Volltext

Verfügbarkeit prüfen

Targeting CCR5 for anti-HIV research

European journal of clinical microbiology & infectious diseases, 2014-11, Vol.33 (11), p.1881-1887

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 613

Suche als RSS-Feed

Aktive Filter

KollektionEZB Free E-Journals

KollektionTaylor & Francis Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(535)
Mit Volltextzugriff
(396)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Chemokine receptor CCR5 antagonist maraviroc: medicinal chemistry and clinical applications

Function-Oriented Development of CXCR4 Antagonists as Selective Human Immunodeficiency Virus (HIV)‑1 Entry Inhibitors

Asymmetric Synthesis of (−)-Brevipolide H through Cyclopropanation of the α,β-Unsaturated Ketone

Design, syntheses, and characterization of piperazine based chemokine receptor CCR5 antagonists as anti prostate cancer agents

Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis

Maraviroc reduces neuropathic pain through polarization of microglia and astroglia – Evidence from in vivo and in vitro studies

The efficacy and safety of maraviroc addition to a stable antiretroviral regimen in subjects with suppressed plasma HIV-RNA is not influenced by age

Inhibition of Inflammatory and Neuropathic Pain by Targeting a Mu Opioid Receptor/Chemokine Receptor5 Heteromer (MOR-CCR5)

Targeting chemokine receptors for HIV: past, present and future

Vaginal rings with exposed cores for sustained delivery of the HIV CCR5 inhibitor 5P12-RANTES

The applications of PCA in QSAR studies: A case study on CCR5 antagonists

Blockade of CCR5 receptor prevents M2 microglia phenotype in a microglia-glioma paradigm

Design and Elaboration of a Tractable Tricyclic Scaffold To Synthesize Druglike Inhibitors of Dipeptidyl Peptidase‑4 (DPP-4), Antagonists of the C–C Chemokine Receptor Type 5 (CCR5), and Highly Potent and Selective Phosphoinositol‑3 Kinase δ (PI3Kδ) Inhibitors

Allosteric mechanism of an oximino‐piperidino‐piperidine antagonist for the CCR5 chemokine receptor

Exploration on natural product anibamine side chain modification toward development of novel CCR5 antagonists and potential anti-prostate cancer agents

Clinical and immunologic effects of maraviroc in progressive multifocal leukoencephalopathy

Medicinal chemistry of small molecule CCR5 antagonists for blocking HIV-1 entry: a review of structural evolution

Molecular Gymnastics: Mechanisms of HIV-1 Resistance to CCR5 Antagonists and Impact on Virus Phenotypes

CCR5 blockade combined with cyclosporine A attenuates liver GVHD by impairing T cells function

CCR5 Blockade Promotes M2 Macrophage Activation and Improves Locomotor Recovery After Spinal Cord Injury in Mice

Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model

Screening HIV-1 fusion inhibitors based on capillary electrophoresis head-end microreactor targeting to the core structure of gp41

Short Communication: Maraviroc Once-Daily: Experience in Routine Clinical Practice

Design, synthesis, and biological activity of novel 1,4-disubstituted piperidine/piperazine derivatives as CCR5 antagonist-based HIV-1 entry inhibitors

Targeting CCR5 for anti-HIV research

Aktive Filter

Suchergebnisse filtern